- Amended Statement of Beneficial Ownership (SC 13D/A)
February 13 2009 - 4:34PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 10 )*
(Name of Issuer)
Series B Common Stock, par value $1.67 per share
(Title of Class of Securities)
(CUSIP Number)
Robert W. Decherd
Belo Corp.
P.O. Box 655237
Dallas, TX 75265
(214) 977-6606
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
o
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 080555 20 4
|
|
13D/A
|
|
Page 2 of 8
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSONS.
Robert W. Decherd
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
(a)
o
|
|
(b)
o
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
|
OO (1)
|
|
|
|
5
|
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
|
|
|
o
|
|
|
|
6
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
United States
|
|
|
|
|
|
7
|
|
SOLE VOTING POWER
|
|
|
|
NUMBER OF
|
|
8,134,754(2)(3)
|
|
|
|
|
SHARES
|
8
|
|
SHARED VOTING POWER
|
BENEFICIALLY
|
|
|
OWNED BY
|
|
23,159(2)(4)
|
|
|
|
|
EACH
|
9
|
|
SOLE DISPOSITIVE POWER
|
REPORTING
|
|
|
PERSON
|
|
8,134,754(2)(3)
|
|
|
|
|
WITH
|
10
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
23,159(2)(4)
|
|
|
|
11
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
8,157,913(2)(3)
|
|
|
|
12
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
|
þ
|
|
|
|
13
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
|
54.7%
|
|
|
|
14
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
|
IN
|
|
|
|
|
|
CUSIP No. 080555 20 4
|
|
13D/A
|
|
Page 3 of 8
|
(1) See Item 3.
(2) Series B common stock is convertible at any time on a share-for-share basis into Series A common stock.
(3) Includes 1,907,013 Series B shares subject to presently exercisable options or options exercisable within 60 days of the date of this Amendment No. 10 to Schedule 13D and 2,180,008 shares indirectly held in grantor retained annuity trusts (collectively,
the GRATs). Such number does not include 1,200 Series B shares owned by Mr. Decherds wife, and 25,000 Series B shares held in trusts established for the benefit of Mr. Decherds daughter (the Daughters
Trusts), as to all of which shares Mr. Decherd disclaims beneficial ownership.
(4) These shares of Series B stock are held by Mr. Decherd in joint tenancy with his wife.
|
|
|
|
|
CUSIP No. 080555 20 4
|
|
13D/A
|
|
Page 4 of 8
|
|
|
|
Item 1. Security and Issuer
|
|
|
Item 2. Identity and Background
|
|
|
Item 3. Source and Amount of Funds or Other Consideration
|
|
|
Item 4. Purpose of Transaction
|
|
|
Item 5. Interest in Securities of the Issuer
|
|
|
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to the Issuer
|
|
|
Item 7. Material to be Filed as Exhibits
|
|
|
SIGNATURE
|
|
|
|
|
|
|
|
CUSIP No. 080555 20 4
|
|
13D/A
|
|
Page 5 of 8
|
This
Amendment No. 10 (this Amendment) to
Schedule 13D is filed to report the following changes to the information previously disclosed in
Amendment No. 9 to Schedule 13D filed February 12, 2007.
Item 1. Security and Issuer
No material change.
Item 2. Identity and Background
No material change.
Item 3. Source and Amount of Funds or Other Consideration.
The Reporting Persons deemed acquisitions reflected in this Amendment No. 10 to Schedule 13D
results from vesting of employee stock options to acquire a total of 240,077 shares of the Issuers
Series B common stock, offset in part by expirations of employee stock options to acquire a total
of 420,000 shares of the Issuers Series B common stock. In addition, 53,000 shares held by a
charitable foundation were sold in February 2007. No funds were expended in connection with the
foregoing transactions.
|
|
|
|
|
CUSIP No. 080555 20 4
|
|
13D/A
|
|
Page 6 of 8
|
Item 4. Purpose of Transaction.
The Reporting Persons deemed acquisition requiring the filing of this Amendment No. 10 to
Schedule 13D is the vesting of employee stock options. The Reporting Person intends to review his
investment in the Issuer on a continuing basis and may, at any time, consistent with the Reporting
Persons obligations under the federal securities laws, determine to increase or decrease his
ownership of shares of the Issuers Series A and B common stock through purchases or sales in the
open market or in privately-negotiated transactions. The Reporting Persons review of his
investment in the Issuer will depend on various factors, including the Issuers business prospects,
other developments concerning the Issuer, general economic conditions, financial and stock market
conditions, the Reporting Persons personal financial situation, need for, and availability of
capital, and any other facts and circumstances which may become known to the Reporting Person
regarding his investment in the Issuer. At the time of filing this Amendment No. 10 to Schedule
13D, the Reporting Person has no plans to purchase additional shares of common stock in the open
market in the immediate future. However, the Reporting Person may engage in privately-negotiated
transactions in the future, may from time-to-time acquire additional shares of common stock under
various employee benefit and compensation arrangements of the Issuer, and reserves his right to
reevaluate his investment in the Issuer and to purchase additional shares in the open market or
otherwise.
Except as may occur in the ordinary course of business of the Issuer, the Reporting Person has
no present plans or proposals which relate to or would result in (i) an extraordinary corporate
transaction, such as a merger, reorganization, or liquidation, involving the Issuer or any of its
subsidiaries, (ii) a sale or transfer of a material amount of assets of the Issuer or any of its
subsidiaries, (iii) any change in the board of directors or executive management of the Issuer or
any of its subsidiaries, (iv) any material change in the present capitalization or dividend policy
of the Issuer, (v) any other material change in the Issuers business or corporate structure, (vi)
changes in the Issuers Certificate of Incorporation or bylaws or other actions that may impede the
acquisition of control of the Issuer by any person, (vii) a series of securities of the Issuer
being delisted from a national securities exchange or no longer being quoted in an inter-dealer
quotation system of a registered national securities association, (viii) a series of equity
securities of the Issuer becoming eligible for termination of registration pursuant to Section
12(g)(4) of the Securities Exchange Act of 1934, or (ix) any action similar to any of those
described above. However, the Reporting Person, in his capacity as Chairman of the Board may, from
time to time, become aware of, initiate, and/or be involved in discussions that relate to the
transactions described in this Item 4 and thus retains his right to modify his plans with respect
to the transactions described in this Item 4 to acquire or dispose of securities of the Issuer and
to formulate plans and proposals that could result in the occurrence of any such events, subject to
applicable laws and regulations.
Item 5. Interest in Securities of the Issuer.
(a) The Reporting Person beneficially owns 8,157,913 shares of the Issuers Series B common
stock, representing approximately 54.7% of the 14,926,746 shares of the Issuers Series B common
stock treated as being outstanding as of December 31, 2008. Such number of shares includes 23,159
Series B shares owned by the Reporting Person and his wife, as to which the Reporting Person shares
voting and dispositive power, 1,907,013 Series B shares subject to
|
|
|
|
|
CUSIP No. 080555 20 4
|
|
13D/A
|
|
Page 7 of 8
|
presently exercisable options or options exercisable within 60 days of the date of this
Amendment No. 10 to Schedule 13D, and 2,180,008 Series B shares indirectly held in the GRATs. Such
number does not include 1,200 Series B shares held by the Reporting Persons wife and 25,000 Series
B shares owned by the Daughters Trusts, as to all of which shares the Reporting Person disclaims
beneficial ownership.
(b) As of the date of this Amendment No. 10 to Schedule 13D, the Reporting Person has sole
voting power of 8,134,754 shares of the Issuers Series B common stock, and sole dispositive power
of 8,134,754 shares of the Issuers Series B common stock, which represents approximately 54.5% of
the shares of the Issuers Series B common stock treated as being outstanding as of December 31,
2008. As of the date of this Amendment No. 10 to Schedule 13D, the Reporting Person has shared
voting power and shared dispositive power over 23,159 shares of the Issuers Series B common stock,
which represents approximately .16% of the shares of the Series B common stock of the Issuer
treated as being outstanding as of December 31, 2008, based upon the number of shares reported by
the Issuer to be outstanding as of December 31, 2008.
(c) Except as disclosed in Item 3, the Reporting Person has not effected any transaction
involving the acquisition or exchange of share of the Series B common stock of the Issuer during
the past 60 days.
(d) The Reporting Persons children are remaindermen of the GRATs.
(e) Not applicable.
Item 6: Contracts, Arrangements, Undertakings or Relationships with Respect to Securities of the
Issuer.
No material change.
Item 7: Material to be Filed as Exhibits.
No material change.
|
|
|
|
|
CUSIP No. 080555 20 4
|
|
13D/A
|
|
Page 8 of 8
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned
certifies that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
Dated: February 5, 2009
|
/s/ Robert W. Decherd
|
|
|
Robert W. Decherd
|
|
|
|
|
|
Belo (NYSE:BLC)
Historical Stock Chart
From May 2024 to Jun 2024
Belo (NYSE:BLC)
Historical Stock Chart
From Jun 2023 to Jun 2024